Skip to content

Clinical study on the effect of GLP-1 receptor agonist ameliorate the visceral adipose tissue of nonalcoholic fatty liver in patients with type 2 diabetes mellitus

Clinical study on the effect of GLP-1 receptor agonist ameliorate the visceral adipose tissue of nonalcoholic fatty liver in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043046
Enrollment
Unknown
Registered
2021-02-04
Start date
2021-02-04
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver in patients with type 2 diabetes mellitus

Interventions

GLP-1RA+Metformin group:GLP-1RA+Metformin

Sponsors

Shandong Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The patients were 18-65 years old; 2. Baseline PDFF content > 6%; 3. HbA1c: 6.5% - 10%; 4. NAFLD; 5. BMI: 20-35kg/m2, with stable weight history; 6. Provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. T1DM; 2. HbA1c > 10%; 3. alcohol consumption > 14 units per week for women and > 21 units per week for men; 4. Patients Taking drugs that can improve the lipid deposition in the liver within 3 months, such as vitamin E, other GLP-1 receptor agonists, sulfonylurea hypoglycemic drugs; 5. Patients suffering from other steatosis , such as pancreatitis, pancreatic cancer, multiple endocrine tumor syndrome type 2, or medullary thyroid carcinoma; 6. Other liver diseases, such as liver tumor, viral hepatitis, autoimmune liver disease, drug-induced liver disease or hereditary liver disease, were found; 7. MRI related contraindication; 8. Pregnant women; 9. The researchers believe that there are other patients who are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
visceal fat content;

Countries

China

Contacts

Public ContactZhao Xinya

Shandong Provincial Hospital Affiliated to Shandong First Medical University

zhaoxinya2000@126.com+86 15168887805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026